AAAAAA
Results: 1-25/64
Authors:
Maattanen, L
Auvinen, A
Stenman, UH
Tammela, T
Rannikko, S
Aro, J
Juusela, H
Hakama, M
Citation: L. Maattanen et al., Three-year results of the Finnish prostate cancer screening trial, J NAT CANC, 93(7), 2001, pp. 552-553
Authors:
Finne, P
Finne, R
Stenman, UH
Citation: P. Finne et al., Neural network analysis of clinicopathological factors in urological disease: a critical evaluation of available techniques, BJU INT, 88(8), 2001, pp. 825-831
Authors:
Prikk, K
Maisi, P
Sepper, R
Stenman, UH
Salo, T
Sorsa, T
Citation: K. Prikk et al., Association of trypsin-2 with activation of gelatinase B and collagenase-2in human bronchoalveolar lavage fluid in vivo, ANN MED, 33(6), 2001, pp. 437-444
Authors:
Louhimo, J
Nordling, S
Alfthan, H
von Boguslawski, K
Stenman, UH
Haglund, C
Citation: J. Louhimo et al., Specific staining of human chorionic gonadotropin beta in benign and malignant gastrointestinal tissues with monoclonal antibodies, HISTOPATHOL, 38(5), 2001, pp. 418-424
Authors:
Hakama, M
Aro, J
Auvinen, A
Juusela, H
Maattanen, L
Stenman, UH
Tammela, TLJ
Citation: M. Hakama et al., Randomized screening trial for prostate cancer in Finland, EUR UROL, 39, 2001, pp. 32-32
Authors:
Finne, P
Auvinen, A
Stenman, UH
Citation: P. Finne et al., Prostate cancer screening, LANCET, 357(9263), 2001, pp. 1201-1201
Authors:
Stattin, P
Stenman, UH
Riboli, E
Hallmans, G
Kaaks, R
Citation: P. Stattin et al., Prostate cancer screening, LANCET, 357(9263), 2001, pp. 1202-1203
Authors:
Sjostrom, J
Alfthan, H
Joensuu, H
Stenman, UH
Lundin, J
Blomqvist, C
Citation: J. Sjostrom et al., Serum tumour markers CA 15-3, TPA, TPS, hCG beta and TATI in the monitoring of chemotherapy response in metastatic breast cancer, SC J CL INV, 61(6), 2001, pp. 431-441
Authors:
Hedstrom, J
Haglund, C
Leinonen, J
Nordling, S
Stenman, UH
Citation: J. Hedstrom et al., Trypsinogen-1,-2 and tumour-associated trypsin-inhibitor in bile and biliary tract tissues from patients with biliary tract diseases and pancreatic carcinomas, SC J CL INV, 61(2), 2001, pp. 111-118
Authors:
Hakama, M
Stenman, UH
Aromaa, A
Leinonen, J
Hakulinen, T
Knekt, P
Citation: M. Hakama et al., Validity of the prostate specific antigen test for prostate cancer screening: Followup study with a bank of 21,000 sera in Finland, J UROL, 166(6), 2001, pp. 2189-2191
Authors:
Makinen, T
Tammela, TLJ
Hakama, M
Stenman, UH
Rannikko, S
Aro, J
Juusela, H
Maattanen, L
Auvinen, A
Citation: T. Makinen et al., Prostate cancer screening within a prostate specific antigen range of 3 to3.9 ng./ml.: A comparison of digital rectal examination and free prostate specific antigen as supplemental screening tests, J UROL, 166(4), 2001, pp. 1339-1342
Authors:
Stenman, UH
Citation: Uh. Stenman, Serial prostate specific antigen, free-to-total prostate specific antigen ratio and complexed prostate specific antigen for the diagnosis of prostatecancer - Comment, J UROL, 166(1), 2001, pp. 98-99
Authors:
Isola, J
Auvinen, A
Poutiainen, M
Kakkola, L
Jarvinen, TAH
Maattanen, L
Stenman, UH
Tammela, T
Hakama, M
Visakorpi, T
Citation: J. Isola et al., Predictors of biological aggressiveness of prostate specific antigen screening detected prostate cancer, J UROL, 165(5), 2001, pp. 1569-1573
Authors:
Paju, A
Jacobsen, J
Rasmuson, T
Stenman, UH
Ljungberg, B
Citation: A. Paju et al., Tumor associated trypsin inhibitor as a prognostic factor in renal cell carcinoma, J UROL, 165(3), 2001, pp. 959-962
Authors:
Stattin, P
Soderberg, S
Hallmans, G
Bylund, A
Kaaks, R
Stenman, UH
Bergh, A
Olsson, T
Citation: P. Stattin et al., Leptin is associated with increased prostate cancer risk: A nested case-referent study, J CLIN END, 86(3), 2001, pp. 1341-1345
Authors:
Vartiainen, J
Lehtovirta, P
Finne, P
Stenman, UH
Alfthan, H
Citation: J. Vartiainen et al., Preoperative serum concentration of hCG beta as a prognostic factor in ovarian cancer, INT J CANC, 95(5), 2001, pp. 313-316
Authors:
Lundin, M
Nordling, S
Lundin, J
Alfthan, H
Stenman, UH
Haglund, C
Citation: M. Lundin et al., Tissue expression of human chorionic gonadotropin beta predicts outcome incolorectal cancer: A comparison with serum expression, INT J CANC, 95(1), 2001, pp. 18-22
Authors:
Stattin, P
Rinaldi, S
Stenman, UH
Riboli, E
Hallmans, G
Bergh, A
Kaaks, R
Citation: P. Stattin et al., Plasma prolactin and prostate cancer risk: A prospective study, INT J CANC, 92(3), 2001, pp. 463-465
Authors:
Stenman, UH
Citation: Uh. Stenman, Immunoassay standardization: Is it possible, who is responsible, who is capable?, CLIN CHEM, 47(5), 2001, pp. 815-820
Authors:
Andersen, JM
Hedstrom, J
Kemppainen, E
Finne, P
Puolakkainen, P
Stenman, UH
Citation: Jm. Andersen et al., The ratio of trypsin-2-alpha(1)-antitrypsin to trypsinogen-1 discriminatesbiliary and alcohol-induced acute pancreatitis, CLIN CHEM, 47(2), 2001, pp. 231-236
Authors:
Lempinen, M
Kylanpaa-Back, ML
Stenman, UH
Puolakkainen, P
Haapiainen, R
Finne, P
Korvuo, A
Kemppainen, E
Citation: M. Lempinen et al., Predicting the severity of acute pancreatitis by rapid measurement of trypsinogen-2 in urine, CLIN CHEM, 47(12), 2001, pp. 2103-2107
Authors:
Turpeinen, U
Methuen, T
Alfthan, H
Laitinen, K
Salaspuro, M
Stenman, UH
Citation: U. Turpeinen et al., Comparison of HPLC and small column (CDTect) methods for disialotransferrin, CLIN CHEM, 47(10), 2001, pp. 1782-1787
Authors:
Paju, A
Sorsa, T
Tervahartiala, T
Koivunen, E
Haglund, C
Leminen, A
Wahlstrom, T
Salo, T
Stenman, UH
Citation: A. Paju et al., The levels of trypsinogen isoenzymes in ovarian tumour cyst fluids are associated with promatrix metalloproteinase-9 but not promatrix metalloproteinase-2 activation, BR J CANC, 84(10), 2001, pp. 1363-1371
Authors:
Hedstrom, J
Kemppainen, E
Andersen, J
Jokela, H
Puolakkainen, P
Stenman, UH
Citation: J. Hedstrom et al., A comparison of serum trypsinogen-2 and trypsin-2-alpha 1-antitrypsin complex with lipase and amylase in the diagnosis and assessment of severity in the early phase of acute pancreatitis, AM J GASTRO, 96(2), 2001, pp. 424-430
Authors:
Stattin, P
Bylund, A
Rinaldi, S
Biessy, C
Dechaud, H
Stenman, UH
Egevad, L
Riboli, E
Hallmans, G
Kaaks, R
Citation: P. Stattin et al., Plasma insulin-like growth factor-I, insulin-like growth factor-binding proteins, and prostate cancer risk: a prospective study, J NAT CANC, 92(23), 2000, pp. 1910-1917